Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Brand-name prescription medicine

Humalog Tempo Pen

Generic name: Insulin lispro

FDA application holder: Lilly

Official data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the NDC Directory, Drugs@FDA, the official labels and recall reports; pharmacy costs come from the Centers for Medicare & Medicaid Services (CMS). Each fact shows its source and date.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or switch any medicine, including a switch between a brand and a generic.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

Quick answers

What is Humalog Tempo Pen?
Humalog Tempo Pen is a brand name of Insulin lispro, a prescription medicine. The FDA NDC Directory lists 1 Humalog Tempo Pen product in 1 strength and form.
Who makes Humalog Tempo Pen?
Lilly holds the FDA application for Humalog Tempo Pen (BLA020563, approved June 14, 1996).
Is there a generic or store brand of Humalog Tempo Pen?
Yes. The FDA NDC Directory lists 22 other products with the same active ingredients, strength and form as a Humalog Tempo Pen product. Ask your pharmacist whether one is right for you.
What do pharmacies pay for Humalog Tempo Pen?
CMS lists a National Average Drug Acquisition Cost (NADAC) for 1 Humalog Tempo Pen strength and form (see the table below). That is what pharmacies pay to buy it, not what you pay: your price depends on your insurance and your pharmacy.
Has Humalog Tempo Pen been recalled?
FDA enforcement reports list 2 recalls of Humalog Tempo Pen products; the newest started March 12, 2024. A recall usually concerns specific lots, not every product.

What Humalog Tempo Pen is

Each Humalog Tempo Pen product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.

Insulin lispro · prescription medicine

Strength and formProduct namesSame medicine, other namesLabel
insulin lispro 100 units/mL
injection, solution (subcutaneous)
Humalog Tempo Pen 22 products, 4 companies DailyMed

Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Insulin lispro →

FDA approval

  • BLA: Biologics License Application: how a biologic medicine (made from living cells) is approved.
FDA applications of Humalog Tempo Pen products (Drugs@FDA)
ApplicationHolderFirst approvedProducts
BLA020563LillyJune 14, 19961

What pharmacies pay (NADAC)

The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.

This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.

NADAC per unit for Humalog Tempo Pen, by strength and form
Strength and formGeneric or brandPharmacies pay
insulin lispro 100 units/mL
injection, solution
Brand: Humalog Tempo Pen $10.13 per mL
Generic of the same strength and form: $2.40–$10.19 per mL

NADAC list of November 4, 2026; these prices took effect on June 17, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.

Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →

Companies that list Humalog Tempo Pen

The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Humalog Tempo Pen products.

Recalls

From FDA enforcement reports, matched by the product’s NDC code or label. A recall usually covers specific lots: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.

  1. March 12, 2024 · Class II · Completed · D-0445-2024

    CGMP Deviations

    Sterile Diluent, HUMALOG U-100 (insulin lispro injection), HUMULIN R U-100 REGULAR (insulin human injection), Insulin Lispro Injection u-100, 10 mL, Use ONLY with Insulins listed on carton, Marketed by: Lilly USA, LLC, I — Eli Lilly & Company

  2. April 5, 2022 · Class I · Completed · D-0882-2022

    TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions due to inclement weather.

    Humalog KwikPen, Insulin lispro injection, U-100, 100 units per mL, 5x3 mL Prefilled Pens per box, Marketed by Lilly USA, LLC, Indianapolis, IN 46285, Box NDC 0002-8799-59, Pen NDC 002-7516-59 — Cardinal Health Inc.

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  4. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
  5. NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026

Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.

Report an error → · Information for medicine makers